Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) issued its earnings results on Monday. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.07, Zacks reports. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.13 million. Cardio Diagnostics had a negative net margin of 34,911.87% and a negative return on equity of 415.33%.
Cardio Diagnostics Stock Up 4.0 %
CDIO traded up $0.02 during midday trading on Wednesday, hitting $0.44. 9,362 shares of the company were exchanged, compared to its average volume of 700,399. The firm’s 50 day moving average price is $0.53 and its 200-day moving average price is $0.99. Cardio Diagnostics has a 1-year low of $0.17 and a 1-year high of $3.56.
Analyst Ratings Changes
Separately, Benchmark raised their price objective on Cardio Diagnostics from $1.35 to $2.00 and gave the company a “speculative buy” rating in a report on Thursday, June 6th.
About Cardio Diagnostics
Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
See Also
- Five stocks we like better than Cardio Diagnostics
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
- What is a Dividend King?
- Microsoft Stock: Is Now The Time To Be Greedy?
- How to Invest in Biotech Stocks
- How to Invest in Mutual Funds
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.